arXiv:2606. 03995v1 Announce Type: cross Abstract: Background: Alzheimer's disease (AD) affects over 55 million people worldwide.
By Afshan Hashmi
arXiv:2607. 22770v1 Announce Type: new Abstract: Although artificial intelligence (AI) has shown promising performance in several medical tasks, accurate dementia etiology diagnosis with AI remains challenging due to complex overlapping symptoms among diseases.
By Siyuan Du, Mengxi Chen, Xinyang Jiang, Zilong Wang, Jiangchao Yao, Dongsheng Li, Ya Zhang, Lili Qiu, Yanfeng Wang
arXiv:2606. 01237v1 Announce Type: new Abstract: Mild cognitive impairment (MCI) and subjective cognitive decline (SCD) are closely associated with the early Alzheimer's disease continuum, where accurate and explainable diagnosis is important for early risk assessment and intervention.
By Xiongri Shen, Jiaqi Wang, Zhenxi Song, Yi Zhong, Leilei Zhao, Xin He, Baiying Lei, Zhiguo Zhang
arXiv:2606. 19371v1 Announce Type: cross Abstract: Alzheimer's disease (AD) is a fatal disorder that destroys memory and cognitive skills in the elderly population.
By Long Doan, Branden Chen, Ethan Litton, Huan Huang, Jiajing Huang, Yixin Xie, Weihua Zhou, Nandakumar Narayanan, Chen Zhao
arXiv:2607. 11656v1 Announce Type: cross Abstract: Accurate diagnostic classification and disease-severity prediction for Alzheimer's disease are hampered by the incompleteness and heterogeneity of real-world clinical data.
By Christelle Schneuwly Diaz, Narmina Baghirova, Duy-Thanh Vu, Duy-Cat Can, Gilles Allali, Philippe Ryvlin, Oliver Y. Ch\'en
arXiv:2606. 20037v1 Announce Type: new Abstract: Alzheimer's disease (AD) is an irreversible neurodegenerative disorder and a leading cause of death worldwide.
By Loukas Ilias, Anthi-Maria Vozinaki, Christos Ntanos, Dimitris Askounis
arXiv:2607. 06629v1 Announce Type: new Abstract: Brain age -- the age inferred from a physiological recording -- is an emerging biomarker whose deviation from chronological age tracks neurological and psychiatric burden, and EEG is an attractive substrate for it because it is cheap, portable, and temporally rich.
By Roy Segal, Yoni Svechinsky, Tomer Fekete
arXiv:2606. 09671v1 Announce Type: cross Abstract: Alzheimer's disease (AD) progression is highly heterogeneous and is typically observed through sparse and irregular longitudinal data, posing challenges for prediction and personalised monitoring.
By Yinyu Huang, Yilin Zhang, Sofia Michopoulou, Christopher Kipps, Rahman Attar
arXiv:2607. 01401v1 Announce Type: cross Abstract: INTRODUCTION: Accurate MRI-based identification of Alzheimer's disease (AD), mild cognitive impairment (MCI), and related dementias remains challenging because disease-related structural changes are often subtle and heterogeneous.
By Mengyu Li, Guoyao Shen, Chad W. Farris, Xin Zhang
arXiv:2607. 24519v3 Announce Type: replace-cross Abstract: EEG foundation-model gains may depend on cohort, montage, or probe design.
By Marzieh Zare
arXiv:2606. 30646v1 Announce Type: cross Abstract: Speech recruits the same executive, attentional, and working memory processes underlying instrumental activities of daily living, or IADLs, providing a non-invasive proxy for cognitive assessment.
By Chukwuemeka Ugwu, Oluwafemi Richard Oyeleke
arXiv:2606. 17867v1 Announce Type: cross Abstract: Despite increasing adoption of multimodal approaches in Alzheimer's Disease (AD) research -- aimed at integrating molecular, structural, clinical, and genetic biomarkers to enhance disease characterization -- the relationships among these modalities remain poorly understood.
By Antonio Scardace, Daniele Rav\`i